Investigation of the effect of intracolonic melatonin gel formulation on acetic acid-induced colitis

References

• Aykac G, Uysal M, Yalcin AS, et al. (1985). The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicol 36:71–6
   PubMed Web of Science ®Google Scholar
• Bubenik GA, Blask DE, Brown GM, et al. (1998). Prospects of the clinical utilization of melatonin. Biol Signals Recept 7:195–219
   PubMedGoogle Scholar
• Casini A, Ferrali M, Pompelam A, et al. (1986). Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene intoxicated mice. Am J Pathol 123:520–31
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Mazzon E, Serraino I. (2001). Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 30:1–12
   PubMed Web of Science ®Google Scholar
• El-Kamel AH, Abdel-Aziz AA, Fatani AJ, et al. (2008). Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. Int J Pharm 358:248–55
   PubMed Web of Science ®Google Scholar
• Fabia R, Willen R, Ar’Rajab A, et al. (1992). Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 24:211–25
   PubMed Web of Science ®Google Scholar
• Frank S, Kampfer H, Wetzler C, et al. (2002). Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int 61:882–8
   PubMed Web of Science ®Google Scholar
• Gombotz WR, Wee SF. (1998). Protein release from alginate matrices. Adv Drug Del Rev 31:267–85
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1126:131–8
   Web of Science ®Google Scholar
• Head KA, Jurenka JS. (2004). Inflammatory bowel disease part II: Crohn’s disease-pathophysiology and conventional and alternative treatment options. Altern Med Rev 9:360–401
   PubMedGoogle Scholar
• Hnin-Ei Thu, Mohd HZ, Shiow-Fern N. (2012). Alginate based bilayer hydrocolloid films as potential slow-release modern wound dressing. Int J Pharm 434:375–83
   PubMed Web of Science ®Google Scholar
• Koffi AA, Agnely F, Besnard M, et al. (2008). In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm 69:167–75
   PubMed Web of Science ®Google Scholar
• Koziol S, Zagulski M, Bilinski T, et al. (2005). Antioxidants protect the yeast Saccharomyces cerevisiae against hypertonic stress. Free Radic Res 39:365–71
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Verspaget HW. (2002). Oxidative stress as a pathogenic factor in inflammatory bowel disease – radicals or ridiculous? Aliment Pharmacol Ther 16:1997–2015
   PubMed Web of Science ®Google Scholar
• Lautenschläger C, Schmidt C, Fischer D, et al. (2014). Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliv Rev 71:58–76
   PubMed Web of Science ®Google Scholar
• Li JH, Yu JP, Yu HG. (2005). Melatonin reduces inflammatory injury through inhibiting NF-κB activation in rats with colitis. Mediators Inflamm 4:185–93
   Web of Science ®Google Scholar
• Lih-Brody L, Powell SR, Collier KP. (1996). Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41:2078–86
   PubMed Web of Science ®Google Scholar
• Marquez E, Sanchez-Fidalgo S, Calvo JR, et al. (2006). Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis. J Pineal Res 40:48–55
   PubMed Web of Science ®Google Scholar
• Mei Q, Xu JM, Xiang L, et al. (2005). Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 81:667–72
   PubMed Web of Science ®Google Scholar
• Mei Q, Yu JP, Xu JM, et al. (2002). Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 23:882–6
   PubMed Web of Science ®Google Scholar
• Millar AD, Rampton DS, Chander CL, et al. (1996). Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407–15
   PubMed Web of Science ®Google Scholar
• Miranda KM, Espey MG, Wink DA, et al. (2001). Simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71
   PubMed Web of Science ®Google Scholar
• Necefli A, Tulumoğlu B, Giriş M. (2006). The effect of melatonin on TNBS-induced colitis. Dig Dis Sci 51:1538–45
   PubMed Web of Science ®Google Scholar
• Nosál'ová V, Zeman M, Cerná S, et al. (2007). Protective effect of melatonin in acetic acid induced colitis in rats. J Pineal Res 42:364–70
   PubMed Web of Science ®Google Scholar
• Oruç N, Kutluana U, Sezak M, et al. (2008). Effects of leflunomide in acetic acid-induced acute colitis in rats. Akademik Gastroenteroloji Dergisi 7:67–72
   Google Scholar
• Paul W, Sharma CP. (2004). Chitosan and alginate wound dressings: a short review. Trends Biomater Artif Organs 18:18–23
   Google Scholar
• Rajinikanth PS, Sankar C, Mishra B. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv 10:21–8
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Terron MP, et al. (2007). Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54:1–9
   PubMed Web of Science ®Google Scholar
• Rybka J, Kedziora-Kornatowska K, Kupczyk D, et al. (2014). Antioxidant effect of immediate-versus sustained-release melatonin intype 2 diabetes mellitus and healthy controls. Drug Deliv, Early Online: 1–4. DOI: 10.3109/10717544.2014.917343
   Google Scholar
• Schwentker A, Vodovotz Y, Weller R, et al. (2002). Nitric oxide and wound repair: role of cytokines? Nitric Oxide 7:1–10
   PubMed Web of Science ®Google Scholar
• Tahan G, Gramignoli R, Marongiu F, et al. (2011). Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci 56:715–20
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ, Chen LD, et al. (1994). Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215–18
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ, Manchester LC, et al. (2002). Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181–97
   PubMedGoogle Scholar
• Terry PD, Villinger F, Bubenik GA, et al. (2009). Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis 15:134–40
   PubMed Web of Science ®Google Scholar
• Triantafillidis A, Triantafillidis JK. (2009). Melatonin: a potent antioxidant agent with anti-inflammatory and anti-apoptotic effects that might be useful in the treatment of IBD patients. Ann Gastroenterol 22:10–12
   Google Scholar
• Tugcu-Demiroz F, Acarturk F, Erdogan D. (2013). Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations. Int J Pharm 457:25–39
   PubMed Web of Science ®Google Scholar
• Tüzün A, Erdil A, Inal V, et al. (2002). Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35:569–72
   PubMed Web of Science ®Google Scholar